The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, China.
Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, China.
Medicine (Baltimore). 2024 Sep 13;103(37):e39679. doi: 10.1097/MD.0000000000039679.
Dahuang Mudan Decoction is commonly used in China for the treatment of acute pancreatitis. Nevertheless, the therapeutic efficacy of the drug remains a subject of debate, and its active ingredients and potential therapeutic targets remain to be determined. The present study used a network pharmacological approach to investigate the active ingredients and possible targets of the drug, and illustrated the clinical effectiveness of Dahuang Mudan Decoction in the treatment of acute pancreatitis by meta-analysis.
The present study investigated the active ingredients of the constituent herbs of Dahuang Mudan Decoction using the TCMID database. In order to further identify molecular targets, Swiss Target Prediction, OMIM and Genecards databases was be used. The present study used metascape database for gene ontology function enrichment analysis and Kyoto Genome Encyclopedia pathway enrichment analysis. A gene interaction network diagram was established for predicting the main targets and mechanism of action to Dahuang Mudan Decoction for acute pancreatitis. To further illustrate the validity of the gene targets and the clinical efficacy of the drug, 13 relevant studies were included for meta-analysis and analyzed using the Cochrane Collaboration's Review Manager 5.4 software.
After a thorough screening process, the present study identified three main components of Dahuang Mudan Decoction: kaempferol, quercetin and eupatin. These three major components have the potential to target 5 important proteins: AKT1, TNF-a, IL-6, TP53, HIF1A. In addition, pathway analyses by the Kyoto Genome Encyclopedia showed that Dahuang Mudan Decoction is active through the Pathways in cancer, AGE-RAGE signaling pathway in diabetic complications, PI3K-Akt signaling pathway, etc signaling pathway to act on acute pancreatitis. The results of meta-analysis showed that compared with the control group, the experimental group had superior performance in terms of overall treatment efficacy, reduction of hospital stays and inflammatory factor levels after treatment.
In summary, network pharmacological studies have shown that Dahuang Mudan Decoction affects acute pancreatitis through different components, targets, and mechanisms. In addition, the meta-analysis study strongly supported the effectiveness of Dahuang Mudan Decoction in the treatment of acute pancreatitis.
大黄牡丹汤在中国常用于治疗急性胰腺炎。然而,该药物的疗效仍存在争议,其活性成分和潜在治疗靶点仍有待确定。本研究采用网络药理学方法研究药物的活性成分和可能的靶点,并通过荟萃分析说明大黄牡丹汤治疗急性胰腺炎的临床疗效。
本研究使用 TCMSP 数据库研究大黄牡丹汤组成草药的活性成分。为了进一步鉴定分子靶点,使用 SwissTargetPrediction、OMIM 和 Genecards 数据库。本研究使用 metabas 数据库进行基因本体功能富集分析和京都基因与基因组百科全书通路富集分析。建立基因相互作用网络图,预测大黄牡丹汤治疗急性胰腺炎的主要靶点和作用机制。为了进一步说明基因靶点的有效性和药物的临床疗效,纳入了 13 项相关研究进行荟萃分析,并使用 Cochrane 协作的 Review Manager 5.4 软件进行分析。
经过彻底的筛选过程,本研究确定了大黄牡丹汤的三种主要成分:山奈酚、槲皮素和泽兰素。这三种主要成分有可能针对 5 种重要蛋白:AKT1、TNF-a、IL-6、TP53、HIF1A。此外,京都基因与基因组百科全书的通路分析表明,大黄牡丹汤通过癌症途径、糖尿病并发症的 AGE-RAGE 信号通路、PI3K-Akt 信号通路等信号通路对急性胰腺炎发挥作用。荟萃分析的结果表明,与对照组相比,实验组在整体治疗效果、住院时间缩短和治疗后炎症因子水平降低方面表现更为出色。
综上所述,网络药理学研究表明,大黄牡丹汤通过不同的成分、靶点和机制影响急性胰腺炎。此外,荟萃分析研究强烈支持大黄牡丹汤治疗急性胰腺炎的有效性。